COMMUNIQUÉS West-GlobeNewswire

HUTCHMED Completes Patient Enrollment of SANOVO Phase III Trial of ORPATHYS® and TAGRISSO® Combination as a First-Line Therapy for Certain Lung Cancer Patients in China
20/08/2025
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Aug. 20, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“ HUTCHMED ”) (Nasdaq/AIM:HCM; HKEX:13) today announces the completion of patient enrollment of SANOVO, a [...]
Dallas Premier No Surgery Hair Replacement Folicure Hair Helps Men Reclaim Their Confidence in New Guide to Recognizing When Hair Loss Calls for Action
20/08/2025
Discover Best Dallas Premier No Surgery Hair Replacement guide to identifying hair loss and exploring tailored hair replacement solutions to regain confidence and restore your hairline. Dallas, TX, Aug. 19, 2025 (GLOBE [...]
REPEAT -- Tevogen Bio Enters Into Agreement for Up to $50 Million in Financing to Advance R&D and Clinical Development Efforts
19/08/2025
Includes $36 million line of credit and potential $14 million private placement WARREN, N.J., Aug. 19, 2025 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings Inc. (“Tevogen” or “Tevogen Bio”) (Nasdaq: TVGN ), a clinical-stage [...]
NMDP Announces Nationwide Celebration and Fundraiser to Help Patients in Need of Life-Saving Cell Therapy
19/08/2025
NMDP Unite will be held simultaneously on Sept. 20—World Marrow Donor Day—in Atlanta, Houston, New York, Minneapolis and Seattle MINNEAPOLIS, Aug. 19, 2025 (GLOBE NEWSWIRE) -- NMDP℠ (formerly Be The Match ® ), a global [...]
Arcutis to Present at Upcoming Investor Conferences
19/08/2025
WESTLAKE VILLAGE, Calif., Aug. 19, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, [...]
Ligand to Participate in September Investor Conferences
19/08/2025
JUPITER, Fla., Aug. 19, 2025 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that Chief Executive Officer Todd Davis and Chief Financial Officer Tavo Espinoza will participate in [...]
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
19/08/2025
SOUTH SAN FRANCISCO, Calif., Aug. 19, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on August 15, 2025 it granted stock options to purchase an aggregate of 105,169 shares of [...]
Celldex Reports Results from Phase 2 Study of Barzolvolimab in Eosinophilic Esophagitis (EoE)
19/08/2025
Study met primary endpoint demonstrating barzolvolimab’s ability to potently deplete mast cells in the gastrointestinal tract Profound mast cell depletion did not result in improved clinical outcomes providing direct [...]
Madrigal Receives European Commission Approval for Rezdiffra™ (resmetirom) for the Treatment of MASH with Moderate to Advanced Liver Fibrosis
19/08/2025
Rezdiffra is the first and only medication approved for people living with MASH in the European Union Conditional marketing authorization is based on positive results from the pivotal Phase 3 MAESTRO-NASH trial [...]
Earth Science Tech, Inc. Board of Directors Approves Reduction of Authorized Common Stock
19/08/2025
Miami, Fla., Aug. 19, 2025 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC: ETST) (“ETST” or the “Company”), a strategic holding company focused on acquiring and scaling high-potential businesses, today announced that [...]
Vivos Therapeutics Reports Second Quarter 2025 Financial Results and Provides Operational Update
19/08/2025
Quarter highlighted by the key acquisition of The Sleep Center of Nevada, which is generating revenue and seeing strong patient demand for Vivos’ differentiated array of highly effective OSA treatments Management to [...]
Scientific Industries Reports Financial Results for Second Quarter of Fiscal Year 2025
19/08/2025
TORBAL DIVISION SALES UP 11% SECURED $10 MILLION IN STRATEGIC DIVESTURE OF GENIE PRODUCT LINE VIVID AND BIOPROCESSING NEW PRODUCT AI ROADMAP ON TARGET Investor Call to be held Wednesday, August 20 th at 11:00 a.m. [...]
NovaBay Pharmaceuticals Enters Into $6 Million Securities Purchase Agreement with Investor David E. Lazar
19/08/2025
Investment to support NovaBay’s continued public listing and provide funding for a future strategic transaction EMERYVILLE, Calif., Aug. 19, 2025 (GLOBE NEWSWIRE) -- NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY [...]
CORRECTION – Bringing Advanced Vascular Diagnostics to the Western US with the SmartVascular Dx™ Test
20/08/2025
IRVINE, Calif., Aug. 19, 2025 (GLOBE NEWSWIRE) -- MorningStar Laboratories, LLC ., (“MSL” or “the Company”), a leading developer of precision diagnostic tests that addresses unmet clinical needs, announced today [...]
Tevogen Delivers Stronger Second Quarter and First Half 2025 Financial Results with Reduced Expenses and Growth Momentum
19/08/2025
Expenses significantly lower with expansion on multiple efforts; Q2 2025 loss from operations reduced to $5.4 million vs $8.6 million in Q2 2024. Tevogen maximizes capital efficiency, maintains access to financing to [...]
MedX Holdings, Inc. (OTC: MEDH) Med X Holdings Q2 2025 Investor Update: We’re at an Inflection Point
19/08/2025
Sales up; on track for ~$1.5M FY25 revenue. Las Vegas lounge approaching approvals. Leaf-trak POS rolling out Q3. Pipeline building in Florida and California. Austin, Texas, Aug. 19, 2025 (GLOBE NEWSWIRE) -- FOR [...]
Epione Beverly Hills Releases Landmark Study Led by Dr. Simon Ourian Confirming Long-Term Effectiveness of Non-Surgical Under-Eye Dark Circle Treatment
19/08/2025
Beverly Hills, CA, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Epione Beverly Hills , a leader in non-invasive aesthetic treatments, announced today the results of a landmark four-year retrospective study evaluating its [...]
Kyowa Kirin Premiers New CTCL Staging Tool for Healthcare Providers
19/08/2025
First-of-its kind tool to guide HCPs on what to consider when staging patients with Mycosis Fungoides and Sézary Syndrome PRINCETON, N.J., Aug. 19, 2025 (GLOBE NEWSWIRE) -- Kyowa Kirin, Inc. a wholly owned subsidiary of [...]
Branded Legacy, Inc. Partners with McMaster University: Revolutionizing Addiction Treatment Through Cutting-Edge Clinical Research and Regulatory Pathways
19/08/2025
Acquisition Poised to Accelerate Life-Saving Interventions, Combining Academic Excellence with Real-World Innovation to Address Global Addiction Crises and Unlock Multi-Billion Market Opportunities VANCOUVER, British [...]

Pages